Document is current
Any future updates will be listed below
-
Authors
Joshi, Nikhil
Mueller, Sabine
Kline, Cassie
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 23 November 2024
First Online: 5 March 2025
Declarations
:
: Dr. Kline serves as the study chair for PNOC029 and Dr. Mueller serves as the IND holder for PNOC029. Bristol Myers Squibb and Day One Biopharmaceuticals provides study drug and clinical trial support for PNOC029.
